• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: Overcoming obstacles of cancer immunotherapy: the important role of emerging nanomedicine.

作者信息

Jiang Aimin, He Wangxiao, Yao Yu

机构信息

Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

Department of Talent Highland, The First Affiliated Hospital of Xi'an Jiao Tong University, Xi'an, China.

出版信息

Front Oncol. 2024 Apr 5;14:1406244. doi: 10.3389/fonc.2024.1406244. eCollection 2024.

DOI:10.3389/fonc.2024.1406244
PMID:38646437
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11026582/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cb/11026582/1817521c2b97/fonc-14-1406244-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cb/11026582/1817521c2b97/fonc-14-1406244-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34cb/11026582/1817521c2b97/fonc-14-1406244-g001.jpg

相似文献

1
Editorial: Overcoming obstacles of cancer immunotherapy: the important role of emerging nanomedicine.社论：克服癌症免疫治疗的障碍：新兴纳米医学的重要作用
Front Oncol. 2024 Apr 5;14:1406244. doi: 10.3389/fonc.2024.1406244. eCollection 2024.
2
Improved cancer immunotherapy strategies by nanomedicine.纳米医学改善癌症免疫疗法策略。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 May-Jun;15(3):e1873. doi: 10.1002/wnan.1873. Epub 2022 Dec 28.
3
Recent advances in tumor microenvironment-targeted nanomedicine delivery approaches to overcome limitations of immune checkpoint blockade-based immunotherapy.肿瘤微环境靶向纳米医学递药方法的最新进展，以克服基于免疫检查点阻断的免疫疗法的局限性。
J Control Release. 2021 Apr 10;332:109-126. doi: 10.1016/j.jconrel.2021.02.002. Epub 2021 Feb 8.
4
Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment.纳米增强免疫疗法：靶向免疫抑制性肿瘤微环境。
Biomaterials. 2024 Mar;305:122463. doi: 10.1016/j.biomaterials.2023.122463. Epub 2024 Jan 6.
5
Combining nanomedicine and immune checkpoint therapy for cancer immunotherapy.将纳米医学与免疫检查点治疗相结合用于癌症免疫治疗。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022 Jan;14(1):e1739. doi: 10.1002/wnan.1739. Epub 2021 Jul 22.
6
Regulation of cancer-immunity cycle and tumor microenvironment by nanobiomaterials to enhance tumor immunotherapy.纳米生物材料调控肿瘤免疫循环和肿瘤微环境增强肿瘤免疫治疗
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 Jul;12(4):e1612. doi: 10.1002/wnan.1612. Epub 2020 Mar 1.
7
Cancer stem cell-immune cell collusion in immunotherapy.癌症干细胞与免疫细胞在免疫疗法中的协同作用。
Int J Cancer. 2023 Aug 15;153(4):694-708. doi: 10.1002/ijc.34421. Epub 2023 Jan 11.
8
TGF-β inhibition combined with cytotoxic nanomedicine normalizes triple negative breast cancer microenvironment towards anti-tumor immunity.TGF-β 抑制联合细胞毒性纳米药物使三阴性乳腺癌微环境正常化，以增强抗肿瘤免疫。
Theranostics. 2020 Jan 12;10(4):1910-1922. doi: 10.7150/thno.36936. eCollection 2020.
9
Stimuli-Sheddable Nanomedicine Overcoming Pathophysiological Barriers for Potentiating Immunotherapy of Cancer.刺激响应型纳米医学克服癌症免疫治疗的病理生理障碍。
J Biomed Nanotechnol. 2021 Aug 1;17(8):1486-1509. doi: 10.1166/jbn.2021.3134.
10
The emerging role of miRNA in the perturbation of tumor immune microenvironment in chemoresistance: Therapeutic implications.miRNA 在肿瘤免疫微环境化疗耐药性改变中的新兴作用：治疗意义。
Semin Cell Dev Biol. 2022 Apr;124:99-113. doi: 10.1016/j.semcdb.2021.04.001. Epub 2021 Apr 15.

引用本文的文献

1
Nanotechnology for boosting ovarian cancer immunotherapy.纳米技术助力卵巢癌免疫治疗。
J Ovarian Res. 2024 Oct 14;17(1):202. doi: 10.1186/s13048-024-01507-z.

本文引用的文献

1
A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists.一种用于共递送肽 neoantigens 和优化的 STING 和 TLR4 激动剂组合的癌症纳米疫苗。
ACS Nano. 2024 Mar 5;18(9):6845-6862. doi: 10.1021/acsnano.3c04471. Epub 2024 Feb 22.
2
Advancing the Boundaries of Immunotherapy in Lung Adenocarcinoma with Idiopathic Pulmonary Fibrosis by a Biomimetic Proteinoid Enabling Selective Endocytosis.通过一种能够实现选择性内吞作用的仿生类蛋白推进特发性肺纤维化伴肺腺癌免疫治疗的边界。
ACS Nano. 2024 Feb 6;18(7):5358-73. doi: 10.1021/acsnano.3c09852.
3
Site-specific controlled-release nanoparticles for immune reprogramming via dual metabolic inhibition against triple-negative breast cancer.
通过双重代谢抑制针对三阴性乳腺癌的免疫重编程的位点特异性控释纳米颗粒。
J Control Release. 2024 Feb;366:204-220. doi: 10.1016/j.jconrel.2023.12.022. Epub 2024 Jan 3.
4
Amplifying cancer treatment: advances in tumor immunotherapy and nanoparticle-based hyperthermia.放大癌症治疗：肿瘤免疫治疗和基于纳米粒子的热疗的进展。
Front Immunol. 2023 Oct 6;14:1258786. doi: 10.3389/fimmu.2023.1258786. eCollection 2023.
5
Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation.推进纳米技术以改善癌症靶向治疗：克服其临床实施中的障碍。
Mol Cancer. 2023 Oct 9;22(1):169. doi: 10.1186/s12943-023-01865-0.
6
Immunotherapy resistance in non-small-cell lung cancer: From mechanism to clinical strategies.非小细胞肺癌的免疫治疗抵抗：从机制到临床策略。
Front Immunol. 2023 Apr 6;14:1129465. doi: 10.3389/fimmu.2023.1129465. eCollection 2023.
7
Targeting drugs to tumours using cell membrane-coated nanoparticles.利用细胞膜包覆的纳米颗粒将药物靶向肿瘤。
Nat Rev Clin Oncol. 2023 Jan;20(1):33-48. doi: 10.1038/s41571-022-00699-x. Epub 2022 Oct 28.
8
Immunotherapy: an alternative promising therapeutic approach against cancers.免疫疗法：一种有前途的癌症治疗方法。
Mol Biol Rep. 2022 Oct;49(10):9903-9913. doi: 10.1007/s11033-022-07525-8. Epub 2022 Jun 27.
9
Turning chiral peptides into a racemic supraparticle to induce the self-degradation of MDM2.将手性肽转变为外消旋超粒子以诱导 MDM2 自我降解。
J Adv Res. 2023 Mar;45:59-71. doi: 10.1016/j.jare.2022.05.009. Epub 2022 Jun 3.
10
Erythrocyte-biomimetic nanosystems to improve antitumor effects of paclitaxel on epithelial cancers.红细胞仿生纳米系统提高紫杉醇对上皮癌的抗肿瘤作用。
J Control Release. 2022 May;345:744-754. doi: 10.1016/j.jconrel.2022.03.060. Epub 2022 Apr 2.